Skip to content
Disclosery

ABG-WTT Global Life Science Capital Partners GP Ltd: LUNG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ABG-WTT Global Life Science Capital Partners GP Ltd on LUNG, newest first. How the timeline and the estimate are built.

ABG-WTT Global Life Science Capital Partners GP Ltd held 0 LUNG shares at 2025-06-30 per its 13F-HR filed 2025-08-14.

the latest 13F is the newest step

  1. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -60,204 shares

    13F-HR 0000950123-25-008425 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-03-31
    13F 60,204 shares
    Change vs previous 13F 0 shares

    1.06% of the 13F portfolio, value $405,173.

    13F-HR 0000950123-25-005578 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-12-31
    13F 60,204 shares
    Change vs previous 13F 0 shares

    0.94% of the 13F portfolio, value $408,785.

    13F-HR 0000950123-25-002368 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-09-30
    13F 60,204 shares
    Change vs previous 13F not available

    2.48% of the 13F portfolio, value $499,091.

    13F-HR 0000950123-24-011466 filed by ABG-WTT Global Life Science Capital Partners GP Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).